<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <title>Unlocking Hope: rTMS for Treatment-Resistant Depression — Westside NeuroTherapeutics</title>
  <meta name="description"
    content="Harvard-led data show rTMS augmentation reduced depressive symptoms more than switching to venlafaxine XR, with response/remission advantages over aripiprazole augmentation." />
  <link rel="canonical" href="https://www.westsideneuro.com/research/breakthrough-treatment-resistant-depression-tms" />
  <link rel="icon"
    href="https://images.squarespace-cdn.com/content/v1/6606fb063699370bf2e12849/4bea3670-97e1-4e95-bd46-ef774955da58/favicon.ico?format=100w" />

  <meta property="og:type" content="article" />
  <meta property="og:url" content="https://www.westsideneuro.com/research/breakthrough-treatment-resistant-depression-tms" />
  <meta property="og:title" content="Unlocking Hope: The Superior Efficacy of rTMS for Treatment-Resistant Depression" />
  <meta property="og:description"
    content="rTMS augmentation outperformed switching to venlafaxine XR for TRD, with favorable response and remission metrics compared to aripiprazole augmentation." />
  <meta property="og:image"
    content="https://images.squarespace-cdn.com/content/v1/624b503b5d73881124e70a24/1649102923989-HOTX3VP5FFBFQY94VTYO/Stocksy_comp_2793634.jpg?format=750w" />
  <meta name="twitter:card" content="summary_large_image" />

  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
  <link href="https://fonts.googleapis.com/css2?family=Pontano+Sans:wght@400;700&display=swap" rel="stylesheet" />

  <style>
    /* === pulled from template.html === */
    :root { --accent:#002c5a; --ink:#0b2545; }
    body { margin:0; font-family:"Pontano Sans",sans-serif; color:#222; line-height:1.6; }
    a { color:var(--accent); text-decoration:none; }
    header { position:sticky; top:0; background:var(--accent); color:#fff; z-index:1000; box-shadow:0 3px 7px rgba(0,0,0,.15); }
    .wrapper { max-width:1400px; margin:0 auto; padding:0 5vw; }
    nav ul { display:flex; flex-wrap:wrap; gap:2rem; list-style:none; margin:0; padding:0.8rem 0; align-items:center; }
    nav a { color:#fff; font-weight:600; }
    nav .brand { font-size:1.3rem; font-weight:700; }
    nav .spacer { margin-left:auto; }

    section { padding:6rem 0; }
    .hero {
      background:url("https://images.squarespace-cdn.com/content/v1/624b503b5d73881124e70a24/1649102923989-HOTX3VP5FFBFQY94VTYO/Stocksy_comp_2793634.jpg?format=1500w") center/cover fixed;
      color:#fff; text-align:center; position:relative;
    }
    .hero::after { content:""; position:absolute; inset:0; background:rgba(0,0,0,0.4); }
    .inner { position:relative; z-index:1; max-width:900px; margin:auto; padding:0 5vw; }

    .eyebrow { text-transform:uppercase; letter-spacing:0.04em; opacity:0.9; font-weight:600; font-size:0.9rem; }
    h1 { margin:0.5rem 0; font-size:2.4rem; line-height:1.15; color:#fff; }
    .meta { font-size:1rem; color:#e0e0e0; margin-top:0.5rem; }
    .lede { font-size:1.15rem; opacity:0.95; margin-top:0.5rem; }

    .prose { max-width:1000px; margin:3rem auto 0; color:#333; }
    .prose h2 { margin:2rem 0 0.6rem; color:var(--ink); }
    .prose p, .prose li { margin:0.8rem 0; }
    .prose ol { padding-left:1.25rem; }
    .callout {
      background:#f6f9fd; border:1px solid #e1ebf7; border-radius:10px; padding:1rem 1.2rem; margin:1.5rem 0;
    }
    .tags { display:flex; flex-wrap:wrap; gap:0.5rem; margin:1.5rem 0; }
    .tag { font-size:0.85rem; color:var(--ink); background:#e8f1fb; border:1px solid #d7e5f7; padding:0.3rem 0.6rem; border-radius:999px; }

    .btn { display:inline-block; padding:0.7em 1.4em; background:var(--accent); color:#fff; font-weight:800; border-radius:6px; margin-top:1.2rem; }
    .btn:hover { box-shadow:0 8px 18px rgba(0,0,0,0.12); }

    footer { background:var(--accent); color:#fff; padding:3rem 0; margin-top:4rem; }
    footer .columns { display:grid; gap:2rem; grid-template-columns:repeat(auto-fit,minmax(160px,1fr)); }
    footer a, footer p { color:#fff; }
  </style>
</head>

<body>
  <!-- HEADER -->
  <header>
    <div class="wrapper">
      <nav>
        <ul>
          <li><a href="/" class="brand">Westside NeuroTherapeutics</a></li>
          <li><a href="../index.html">Home</a></li>
          <li><a href="../ourapproach.html">About</a></li>
          <li><a href="../services.html">Services</a></li>
          <li><a href="../tms.html">TMS</a></li>
          <li><a href="../research.html">Research</a></li>
          <li><a href="../contact.html">Contact</a></li>
          <li class="spacer"></li>
          <li><a href="https://calendly.com/rebekawestsideneuro/30min" class="btn">Free Consult</a></li>
        </ul>
      </nav>
    </div>
  </header>

  <!-- HERO -->
  <section class="hero" style="padding:6rem 0 4rem;">
    <div class="inner">
      <div class="eyebrow">Research Explained</div>
      <h1>Unlocking Hope: The Superior Efficacy of rTMS for Treatment-Resistant Depression</h1>
      <div class="meta">May 15 • Written by Jezabel May</div>
      <p class="lede">
        Harvard-led data show rTMS augmentation reduced depressive symptoms more than switching to venlafaxine XR, with better response and remission outcomes than aripiprazole augmentation.
      </p>
      <a href="../research.html" class="btn">← Back to Research</a>
    </div>
  </section>

  <!-- ARTICLE -->
  <section class="prose">
    <h2>Major Finding</h2>
    <p>
      This study highlights the superior effectiveness of repetitive Transcranial Magnetic Stimulation (rTMS) for individuals with Major Depressive Disorder unresponsive to prior treatment. In head-to-head trials, <strong>rTMS augmentation outperformed switching to venlafaxine XR</strong>, and showed advantages over aripiprazole augmentation in response and remission rates.
    </p>

    <h2>Cool Fact</h2>
    <p>
      Westside NeuroTherapeutics was a data collection site for this Harvard-led trial, with our own <strong>Dr. Alexander Bystritsky</strong> serving as Primary Investigator (PI).
    </p>

    <h2>The Problem</h2>
    <p>
      For patients with Treatment-Resistant Depression (TRD), standard medication pathways frequently fail, leaving symptoms unresolved.
    </p>

    <h2>The Solution</h2>
    <p>
      <strong>TMS</strong> is a non-invasive therapy targeting brain regions involved in mood regulation. Used as augmentation to existing antidepressants, rTMS provides meaningful clinical benefit in TRD.
    </p>

    <h2>The Study</h2>
    <ol>
      <li><strong>Aripiprazole (Abilify) augmentation</strong>: add aripiprazole to current antidepressant.</li>
      <li><strong>rTMS augmentation</strong>: add rTMS to current antidepressant.</li>
      <li><strong>Switch to venlafaxine XR (Effexor)</strong>: discontinue current antidepressant and begin venlafaxine XR.</li>
    </ol>

    <h2>The Results</h2>
    <p>
      On the <em>Montgomery–Åsberg Depression Rating Scale (MADRS)</em>, over 8 weeks the <strong>rTMS augmentation group achieved greater symptom reduction</strong> than the venlafaxine XR switch group (≈4.2 points). Response and remission measures also favored rTMS over both aripiprazole and venlafaxine XR.
    </p>

    <h2>The Conclusion</h2>
    <p>
      <strong>rTMS augmentation</strong> is more effective than switching to venlafaxine XR for TRD. While aripiprazole augmentation was superior to venlafaxine XR, it did not match the efficacy of rTMS. For many who have exhausted medication options, rTMS augmentation offers a breakthrough path forward.
    </p>

    <div class="tags">
      <span class="tag">Depression</span>
      <span class="tag">MDD</span>
      <span class="tag">TRD</span>
      <span class="tag">TMS</span>
      <span class="tag">Research</span>
    </div>

    <div class="callout">
      <strong>Citation:</strong> Harvard-led clinical trial data, with summaries cross-referenced to BrainsWay knowledge center and post-marketing evidence.
    </div>

    <p style="margin-top:2rem;">
      <a href="../tms.html" class="btn">Learn about TMS</a>
      <a href="https://calendly.com/rebekawestsideneuro/30min" class="btn">Free Consult</a>
    </p>
  </section>

  <!-- FOOTER -->
  <footer>
    <div class="wrapper columns">
      <div>
        <img src="../src/Full_Logo_Transparent_Background2.png" alt="Westside NeuroTherapeutics logo"
          style="width:100%;border-radius:8px;background:var(--accent)" />
      </div>
      <div>
        <p><strong>Stay in touch – it's good for your head!</strong></p>
        <p><a href="../contact.html">Contact Us</a></p>
      </div>
      <div>
        <p><a href="../ourapproach.html">About</a><br />
          <a href="../services.html">Services</a><br />
          <a href="../team.html">Team</a></p>
      </div>
      <div>
        <p><a href="../blog.html">Blog</a><br />
          <a href="../contact.html">Get Started</a><br />
          <a href="/privacy-policy">Privacy Policy</a></p>
      </div>
    </div>
  </footer>
</body>
</html>
